Key terms

About BMRN

BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997, and is headquartered in San Rafael, CA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest BMRN news

Yesterday 10:11pm ET Analysts Offer Insights on Healthcare Companies: Thermo Fisher (TMO), Conmed (CNMD) and BioMarin Pharmaceutical (BMRN) by TipRanks Yesterday 6:53am ET Biotech Sector: M&A Fuels Renewed Excitement by TipRanks Yesterday 2:12am ET Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), BioMarin Pharmaceutical (BMRN) and Hookipa Pharma (HOOK) by TipRanks Apr 26 10:52am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Apr 26 7:43am ET BioMarin price target lowered to $89 from $91 at Canaccord by TipRanks Apr 26 7:20am ET Analysts Offer Insights on Healthcare Companies: AstraZeneca (AZN) and BioMarin Pharmaceutical (BMRN) by TipRanks Apr 26 5:27am ET Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (BMRN), PTC Therapeutics (PTCT) and Teladoc (TDOC) by TipRanks Apr 26 1:57am ET Buy Rating Affirmed for BioMarin Pharmaceutical Amidst Strong Earnings and Voxzogo’s Growth Potential by TipRanks Apr 25 9:31am ET BioMarin price target raised to $85 from $83 at Scotiabank by TipRanks Apr 25 7:56am ET Oppenheimer Keeps Their Hold Rating on BioMarin Pharmaceutical (BMRN) by TipRanks Apr 25 7:51am ET Analysts Offer Insights on Healthcare Companies: CureVac (CVAC) and BioMarin Pharmaceutical (BMRN) by TipRanks Apr 25 7:33am ET BioMarin price target lowered to $91 from $94 at Citi by TipRanks Apr 25 7:32am ET Analysts’ Top Healthcare Picks: BioMarin Pharmaceutical (BMRN), Universal Health (UHS) by TipRanks Apr 25 7:28am ET Scotiabank Reaffirms Their Hold Rating on BioMarin Pharmaceutical (BMRN) by TipRanks Apr 25 7:02am ET Analysts Offer Insights on Healthcare Companies: Biogen (BIIB), Evolent Health (EVH) and BioMarin Pharmaceutical (BMRN) by TipRanks Apr 24 4:08pm ET BioMarin raises FY24 adjusted EPS view to $2.75-$2.95 from $2.60-$280 by TipRanks Apr 24 4:05pm ET BioMarin reports Q1 non-GAAP EPS 71c, consensus 34c by TipRanks Apr 24 3:44pm ET BioMarin options imply 5.4% move in share price post-earnings by TipRanks Apr 24 8:00am ET Analysts Offer Insights on Healthcare Companies: Biogen (BIIB) and BioMarin Pharmaceutical (BMRN) by TipRanks Apr 24 5:37am ET Buy Rating Affirmed on BioMarin Amid Voxzogo Success and Promising Growth Outlook by TipRanks Apr 22 8:28am ET BioMarin Pharmaceutical (BMRN) Receives a Buy from Piper Sandler by TipRanks Apr 22 7:17am ET BioMarin price target raised to $110 from $100 at Cantor Fitzgerald by TipRanks Apr 15 7:35pm ET Buy Rating Affirmed for BioMarin Pharmaceutical Amidst Strong Sales Outlook and Optimized Market Expectations by TipRanks Apr 12 11:25am ET BioMarin participates in a conference call with JPMorgan. by TipRanks Apr 12 8:33am ET Analysts Are Bullish on These Healthcare Stocks: BioMarin Pharmaceutical (BMRN), Regeneron (REGN) by TipRanks Apr 12 4:55am ET BioMarin participates in a conference call with JPMorgan. by TipRanks Apr 11 5:29pm ET BioMarin participates in a conference call with JPMorgan. by TipRanks Apr 08 10:40pm ET Analysts Offer Insights on Healthcare Companies: Incyte (INCY), BioMarin Pharmaceutical (BMRN) and ACADIA Pharmaceuticals (ACAD) by TipRanks Mar 26 7:10am ET Analysts’ Opinions Are Mixed on These Healthcare Stocks: Day One Biopharmaceuticals (DAWN), BioMarin Pharmaceutical (BMRN) and Argenx Se (ARGX) by TipRanks Mar 13 8:25am ET Buy Rating Justified by Voxzogo’s Efficacy in Hypochondroplasia Treatment: A Deep Dive into BioMarin Pharmaceutical’s Clinical Data by TipRanks Mar 13 7:11am ET Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (BMRN), Bioventus (BVS) and Pliant Therapeutics (PLRX) by TipRanks

No recent press releases are available for BMRN

BMRN Financials

1-year income & revenue

Key terms

BMRN Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

BMRN Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

The Marriner S. Eccles Federal Reserve building in Washington, DC, on Thursday, Dec. 28, 2023.
Valerie Plesch/Bloomberg/Getty Images
The Fed announced a big change today. And no, we’re not talking about interest rates
A Dave & Buster's location in the Gateway Center shopping complex in the Brooklyn borough of New York, US, on Saturday, March 30, 2024. Dave & Buster's Entertainment Inc. is scheduled to release earnings figures on April 2. Photographer: Bing Guan/Bloomberg
Bing Guan/Bloomberg/Getty Images
Dave and Buster’s is getting into the betting business
All three major indexes closed out April lower, snapping a five-month streak of gains.
Michael M Santiago/Getty Images
Dow closes 570 points lower, capping losing month for stocks ahead of Fed decision
The Federal Reserve building is seen before the Federal Reserve board is expected to signal plans to raise interest rates in March as it focuses on fighting inflation in Washington, U.S., January 26, 2022.
Joshua Roberts/Reuters/File
When will the Fed begin to cut interest rates? It’s a mystery